House and Senate Democratic leaders on health committees are calling for the Trump administration to withdraw its new guidance changing the purpose of 1332 waivers, arguing the guidance is inconsistent with congressional intent and could reduce patients’ access to care, especially for those with preexisting conditions, and increase health care costs by expanding the use of short-term plans.